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Novel Relapsing 
Fever Spirochete in 
Bat Tick
To the Editor: Tick-borne relaps-
ing fever in western North America is 
a zoonosis caused by spirochetes in 
the genus Borrelia that are transmit-
ted by argasid ticks of the genus Or-
nithodoros (1). Human disease occurs 
in many focal areas and is associated 
with infections of Borrelia hermsii, 
B. turicatae, and possibly B. parkeri 
(2,3). Although the ecologic param-
eters that maintain B. hermsii and B. 
turicatae differ, human infections usu-
ally occur in rustic cabins (B. hermsii) 
and caves (B. turicatae) inhabited by 
ticks and their terrestrial vertebrate 
hosts (1). Recently, Gill et al. (4) pro-
vided evidence that the argasid bat 
tick,  Carios kelleyi, feeds upon hu-
mans. Subsequently, Loftis et al. (5) 
used PCR analysis and DNA sequenc-
ing to detect in C. kelleyi an unidenti-
ﬁ  ed Borrelia species that was closely 
related to B. turicatae and B. parkeri. 
We report the partial molecular char-
acterization of another novel tick-
borne relapsing fever spirochete in C. 
kelleyi, which expands our knowledge 
for this group of pathogenic spiro-
chetes and their potential vertebrate 
hosts and tick vectors.
C. kelleyi were collected Au-
gust 18, 2005, from a house in Jones 
County, Iowa, built in 1857. Bats had 
been excluded from the attic since 
1992. Nine months before ticks were 
collected, bats were prevented from 
roosting under the eaves. DNA was 
extracted from 31 nymphal C. kel-
leyi, as described previously (6). For 
each tick, regions of the glpQ, ﬂ  aB, 
and 16S rRNA genes were ampliﬁ  ed 
and sequenced as described (3,7,8). 
Sequences were assembled by using 
the SeqMan program in the Lasergene 
software package (DNASTAR, Madi-
son, WI, USA).
Fourteen (45.1%) of 31 ticks were 
positive by PCR for >1 of the genes 
tested. Partial DNA sequences were 
determined from tick no. 16, for which 
amplicons for all 3 genes were ob-
tained. The partial ﬂ  aB sequence had 
4 bases different from the 300-base 
sequence (98.66% identity) reported 
previously (GenBank accession no. 
AY763104) for another Borrelia  sp. 
found in C. kelleyi (5). We constructed 
a 1,992-bp concatenated sequence 
that contained 1,273 bp of the 16S 
rRNA, 351 bp of ﬂ  aB, and 368 bp of 
glpQ. This concatenated sequence was 
aligned with homologous, trimmed 
DNA sequences of the same length ob-
tained from representative full-length 
sequences determined previously 
for  B. hermsii,  B. turicatae, and B. 
parkeri (3,9) (Figure). This C. kelleyi 
spirochete was more closely related to 
B. turicatae and B. parkeri than to B. 
hermsii but was clearly distinct from 
all 3 species (DNA sequence identities 
of 98.89%, 98.75%, and 95.98% to B. 
turicatae, B. parkeri, and B. hermsii, 
respectively).
A  glpQ amplicon from another 
nymphal tick (no. 3) was sequenced 
(GenBank accession no. EF688578) 
and was unique in the database; it was 
also considerably different from the 
glpQ sequence determined from tick 
16, with 325 of 368 bases matching 
(88.3% identity). The Borrelia glpQ se-
quence from tick 3 had 85.1%–89.1% 
identity compared with glpQ sequenc-
es from B. hermsii, B. turicatae, and B. 
parkeri. This ﬁ  nding suggests the pres-
ence of at least 2 relapsing fever group 
spirochetes in C. kelleyi that await fur-
ther characterization.
We found a novel Borrelia in bat 
ticks that is closely related to, but dis-
tinct from, the other known species of 
tick-borne relapsing fever spirochetes 
in North America. The human health 
implications of the new relapsing fever 
group spirochete are not yet known. 
The willingness of C. kelleyi to feed 
on humans and the fact that infection 
with bacteria closely related to true 
relapsing fever spirochetes occurs in 
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Figure. Phylogram comparing the novel spirochete in the bat tick Carios kelleyi with 
Borrelia parkeri,  B. turicatae, and B. hermsii based on the concatenated partial 16S 
rRNA-ﬂ  aB-glpQ DNA sequences in the Carios spirochete (1,992 bp total) (produced with 
ClustalV software from DNASTAR [Madison, WI, USA]). Scale bar represents the number 
of base substitutions per 100 aligned bases. GenBank accession numbers for the C. kelleyi 
spirochete sequences used to construct the tree are EF688575, EF688576, and EF688577. 
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these ticks suggest that human habita-
tion near bats and their associated tick 
colonies could pose a public health 
risk. Growth in laboratory animals or 
culture could help isolate these novel 
organisms for further studies to estab-
lish the distribution and public health 
implications of this newly identiﬁ  ed 
Borrelia sp.
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KI and WU 
Polyomaviruses in 
Children, France 
To the Editor: Two new mem-
bers of the Polyomaviridae family, 
provisionally named Karolinska In-
stitutet virus (KIPyV) and Washing-
ton University virus (WUPyV), have 
been recently discovered (1,2). These 
new polyomaviruses were identiﬁ  ed 
by screening human respiratory se-
cretions with molecular tools. KIPyV 
and WUPyV are genetically related to 
the BK virus and the JC virus, the 2 
known members of the family Poly-
omaviridae that affect humans.
In France, from November 2006 
through June 2007, nasopharyngeal 
aspirates were obtained from 537 chil-
dren who were <5 years of age and 
who had acute respiratory tract disease. 
The aspirates were tested for respira-
tory syncytial virus (RSV); inﬂ  uenza 
virus types A and B; parainﬂ  uenza vi-
rus types 1, 2, and 3; and adenoviruses 
(AdVs) by direct immunoﬂ  uorescence 
assay. The aspirates were also tested 
for human metapneumovirus (HMPV) 
by an enzyme immunoassay (HMPV 
EIA, Biotrin, Lyon, France) and for 
the human bocavirus (HBoV) by PCR 
(3). Samples were placed on MRC5 
cell monolayers for virus isolation.
Nucleic acid extracts were tested 
for KIPyV and WUPyV DNA by PCR. 
KIPyV detection was performed by us-
ing a nested PCR approach that target-
ed the VP1 capsid gene as described 
by Allander et al. (1). For WUPyV 
detection, primers targeted the pre-
dicted 3′ end of the large T antigen 
coding region as described by Gaynor 
et al. (2). The ampliﬁ  cation speciﬁ  city 
was assessed by sequencing the PCR 
product; sequences were deposited in 
GenBank (WUPyV isolates, accession 
no. AM778536–48; KIPyV isolates, 
accession no. AM849808–10).
At least 1 type of virus was identi-
ﬁ  ed for 271 (50.5%) children. The vi-
ruses found were RSVs in 175 (32.6%), 
HBoVs in 54 (10.0%), HMPVs in 50 
(9.3%), rhinoviruses/enteroviruses in 
11 (2%), inﬂ   uenza A viruses in 8 
(1.5%), human AdVs in 6 (1.1%), 
and parainﬂ  uenza type 3 viruses in 4 
(0.7%) samples. Aspirates were not 
tested for coronaviruses; detection of 
rhinoviruses/enteroviruses was likely 
low because cell culture is less sensi-
tive than molecular assays.
A total of 13 (2.4%) samples 
were positive for WUPyV; of these 4 
(30.8%) were co-infected with another 
virus. The 13 children with samples 
positive for WUPyV had a median age 
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